Contagion&reg Editorial Staff

Here is a look back at approvals, clearances, and authorizations granted by the US Food and Drug Administration for infectious disease products in 2019.

Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of December 22, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Daniel B. Chastain, PharmD, BCIDP, AAHIVP, discusses a retrospective study of errors occurring in the treatment of patients with HIV.

Contagion® counts down the top HIV news stories of 2019, including FDA approvals, breakthrough discoveries, recommendations from the frontlines, and a big-picture look at just how close we are to ending the epidemic.

Jason Tokumoto, MD, discusses how occupying the role of both patient and physician can provide a human perspective on HIV care.

From Ebola to measles to Salmonella, these were the top 9 infectious disease outbreaks of 2019.

Brenna Hughes, MD, MSc, explains why we need more effective options for congenital CMV.

Study finds coinfection is unlikely as Europe braces for influenza A.

Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, weighs in on the role of guidelines in ID treatment.

Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of December 15, 2019.

We’ve round up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Ervebo has been approved for the prevention of Ebola virus disease, caused by Zaire ebolavirus in individuals 18 years of age and older.

Pamela Gorman, RN, ACRN, discusses the importance of clinics having team members who come from the community patients are being recruited from.

Jason Tokumoto, MD, discusses recent developments in HIV treatment and prevention, focusing on the impact of “U=U.”

Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of December 8, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

The US Food and Drug Administration today cleared for marketing the first fully disposable duodenoscope.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Jason Schafer, PharmD, MPH, BCPS AQ-ID, discusses upcoming long-acting therapies for HIV.

Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, previews his editor-in-chief letter for the December issue.

Brenna Hughes, MD, MSc, discusses the hypothesis that CMV hyperimmune globulin could have an effect on stopping congenital infections and results of a trial.

Gregory Felzien, MD, AAHIVS, highlights “clinic champions” who help move patient care forward while facing external constraints.

Carlos del Rio, MD, discusses advances in long-acting antiretrovirals and the costs associated with HIV therapies.

Representatives from the AIDS Care Group discuss the racial disparities that exist in the HIV/AIDS care continuum for women of color, as well as how a peer engagement and retention program can help.

Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of December 1, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

In the December issue of Contagion®, Carlos del Rio, MD, Debra Goff, PharmD, and Paul Sax, MD, discuss the benefit of infectious disease clinicians using Twitter.